Homotherapy for heteropathy of chronic kidney disease and oligoasthenozoospermia through regulating SIRT1/NF-κB pathway by Shenqi pills

BackgroundChronic kidney disease (CKD), defined by a glomerular filtration rate (GFR) below 60 mL/min/1.73 m2 for over 3 months, is a significant global health concern, often progressing to end-stage renal disease (ESRD). Oligoasthenospermia (OA), characterized by reduced sperm count or quality, aff...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Shuo Huang, Qihan Luo, Xinyue Li, Yiming Liu, Jiale Wei, Sichen Wang, Ping Qiu, Changyu Li
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2025-06-01
Ráidu:	Frontiers in Pharmacology
Fáttát:	shenqi pill homotherapy for heteropathy SIRT1/NF-κB pathway chronic kidney disease oligoasthenospermia
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1551423/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!